Clinical significance of Janus kinase inhibitors in the therapy of rheumatoid arthritis: achievements and prospects
| Autor: | V. I. Mazurov, I. B. Belyaeva |
|---|---|
| Jazyk: | ruština |
| Rok vydání: | 2019 |
| Předmět: | |
| Zdroj: | Современная ревматология, Vol 13, Iss 4, Pp 116-123 (2019) |
| Druh dokumentu: | article |
| ISSN: | 1996-7012 2310-158X |
| DOI: | 10.14412/1996-7012-2019-4-116-123 |
| Popis: | Significant successes in the use of biological agents (BA) have been achieved in the treatment of rheumatoid arthritis (RA); nonetheless, about 36% of patients cannot respond to therapy or achieve the expected effect. A new area in the treatment of RA is the use of Janus kinase (JAK) inhibitors, targeted synthetic disease-modifying anti-rheumatic drugs (chemical molecules with a molecular weight |
| Databáze: | Directory of Open Access Journals |
| Externí odkaz: |
|